Biblio

Export 335 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is I  [Clear All Filters]
Journal Article
M. Tahmi, Rippon, B., Palta, P., Sherwood, G., Hernandez, G., Soto, L., Ceballos, F., Pardo, M., Laing, K., Igwe, K., He, H., Teresi, J. A., Moreno, H., Razlighi, Q., Brickman, A. M., and Luchsinger, J. A., “In Vivo Amyloid, Neurodegeneration, and Verbal Learning in Late Middle-Aged Hispanics.”, J Alzheimers Dis, vol. 82, no. 1, pp. 317-325, 2021.
K. Nakaizumi, Ouchi, Y., Terada, T., Yoshikawa, E., Kakimoto, A., Isobe, T., Bunai, T., Yokokura, M., Suzuki, K., and Magata, Y., “In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1355-1365, 2018.
A. Ishikawa, Tokunaga, M., Maeda, J., Minamihisamatsu, T., Shimojo, M., Takuwa, H., Ono, M., Ni, R., Hirano, S., Kuwabara, S., Ji, B., Zhang, M. - R., Aoki, I., Suhara, T., Higuchi, M., and Sahara, N., “In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1037-1052, 2018.
S. Musunuri, Khoonsari, P. Emami, Mikus, M., Wetterhall, M., Häggmark-Mänberg, A., Lannfelt, L., Erlandsson, A., Bergquist, J., Ingelsson, M., Shevchenko, G., Nilsson, P., and Kultima, K., “Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1671-1686, 2016.
E. Nikitidou, Khoonsari, P. Emami, Shevchenko, G., Ingelsson, M., Kultima, K., and Erlandsson, A., “Increased Release of Apolipoprotein E in Extracellular Vesicles Following Amyloid-β Protofibril Exposure of Neuroglial Co-Cultures.”, J Alzheimers Dis, vol. 60, no. 1, pp. 305-321, 2017.
R. Sala-Llonch, Idland, A. - V., Borza, T., Watne, L. Otto, Wyller, T. Bruun, Brækhus, A., Zetterberg, H., Blennow, K., Walhovd, K. Beate, and Fjell, A. Martin, “Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition.”, J Alzheimers Dis, vol. 58, no. 3, pp. 829-840, 2017.
Y. Hattori, Maki, T., Saito, S., Yamamoto, Y., Nagatsuka, K., and Ihara, M., “Influence of Low-Dose Aspirin on Cerebral Amyloid Angiopathy in Mice.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1037-45, 2016.
Y. Yoshino, Yamazaki, K., Ozaki, Y., Sao, T., Yoshida, T., Mori, T., Mori, Y., Ochi, S., Iga, J. - I., and Ueno, S. - I., “INPP5D mRNA Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.”, J Alzheimers Dis, vol. 58, no. 3, pp. 687-694, 2017.
S. Preethy, Ranganathan, N., Raghavan, K., Dedeepiya, V. Devaprasad, Ikewaki, N., and Abraham, S. J. K., “Integrating the Synergy of the Gut Microbiome into Regenerative Medicine: Relevance to Neurological Disorders.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1451-1460, 2022.
M. Ienca, Fabrice, J., Elger, B., Caon, M., Pappagallo, A. Scoccia, Kressig, R. W., and Wangmo, T., “Intelligent Assistive Technology for Alzheimer's Disease and Other Dementias: A Systematic Review.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1301-1340, 2017.
I. Frentz, van Arendonk, J., Leeuwis, A. E., Vernooij, M. W., van der Flier, W. M., Bos, D., De Deyn, P. Paul, Wolters, F. J., and M Ikram, A., “Interaction Between Arteriosclerosis and Amyloid-β on Cognitive Function.”, J Alzheimers Dis, vol. 97, no. 2, pp. 953-961, 2024.
W. Hu, Tung, Y. Chyn, Zhang, Y., Liu, F., and Iqbal, K., “Involvement of Activation of Asparaginyl Endopeptidase in Tau Hyperphosphorylation in Repetitive Mild Traumatic Brain Injury.”, J Alzheimers Dis, vol. 64, no. 3, pp. 709-722, 2018.
A. Gamir-Morralla, Belbin, O., Fortea, J., Alcolea, D., Ferrer, I., Lleo, A., and Iglesias, T., “Kidins220 Correlates with Tau in Alzheimer's Disease Brain and Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1327-1333, 2017.
C. E. Fischer, Qian, W., Schweizer, T. A., Millikin, C. P., Ismail, Z., Smith, E. E., Lix, L. M., Shelton, P., and Munoz, D. G., “Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 1, pp. 283-95, 2016.
P. Bharadwaj, Wijesekara, N., Liyanapathirana, M., Newsholme, P., Ittner, L., Fraser, P., and Verdile, G., “The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.”, J Alzheimers Dis, vol. 59, no. 2, pp. 421-432, 2017.
M. Ihara and Washida, K., “Linking Atrial Fibrillation with Alzheimer's Disease: Epidemiological, Pathological, and Mechanistic Evidence.”, J Alzheimers Dis, vol. 62, no. 1, pp. 61-72, 2018.
T. Kawarabayashi, Nakamura, T., Sato, K., Seino, Y., Ichii, S., Nakahata, N., Takatama, M., Westaway, D., St George-Hyslop, P., and Shoji, M., “Lipid Rafts Act as a Common Platform for Amyloid-β Oligomer-Induced Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1189-1203, 2022.
R. Freak-Poli, Wagemaker, N., Wang, R., Lysen, T. S., M Ikram, A., Vernooij, M. W., Dintica, C. S., Vernooij-Dassen, M., Melis, R. J. M., Laukka, E. J., Fratiglioni, L., Xu, W., and Tiemeier, H., “Loneliness, Not Social Support, Is Associated with Cognitive Decline and Dementia Across Two Longitudinal Population-Based Cohorts.”, J Alzheimers Dis, vol. 85, no. 1, pp. 295-308, 2021.
Y. Inui, Ito, K., and Kato, T., “Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 877-887, 2017.
Y. Inui, Ito, K., and Kato, T., “Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study.”, J Alzheimers Dis, vol. 60, no. 3, pp. 877-887, 2017.
A. Ka Sin Phua, Hiu, S. Kuan Wei, Goh, W. King, Ikram, M. Kamran, Venketasubramanian, N., Tan, B. Yeow, Chen, C. Li- Hsian, and Xu, X., “Low Accuracy of Brief Cognitive Tests in Tracking Longitudinal Cognitive Decline in an Asian Elderly Cohort.”, J Alzheimers Dis, vol. 62, no. 1, pp. 409-416, 2018.
F. Cacciamani, Tandetnik, C., Gagliardi, G., Bertin, H., Habert, M. - O., Hampel, H., Boukadida, L., Révillon, M., Epelbaum, S., and Dubois, B., “Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 2, pp. 753-762, 2017.
T. Xiao, Wijnant, S. R. A., Licher, S., Terzikhan, N., Lahousse, L., M Ikram, K., Brusselle, G. G., and M Ikram, A., “Lung Function Impairment and the Risk of Incident Dementia: The Rotterdam Study.”, J Alzheimers Dis, vol. 82, no. 2, pp. 621-630, 2021.
T. Xiao, Wijnant, S. R. A., Licher, S., Terzikhan, N., Lahousse, L., M Ikram, K., Brusselle, G. G., and M Ikram, A., “Lung Function Impairment and the Risk of Incident Dementia: The Rotterdam Study.”, J Alzheimers Dis, vol. 82, no. 2, pp. 621-630, 2021.
J. - C. Delgado-González, Florensa-Vila, J., Mansilla-Legorburo, F., Insausti, R., and Artacho-Pérula, E., “Magnetic Resonance Imaging and Anatomical Correlation of Human Temporal Lobe Landmarks, in 3D Euclidean Space: A Study of Control and Alzheimer's Disease Subjects.”, J Alzheimers Dis, vol. 57, no. 2, pp. 461-473, 2017.

Pages